PMID: 8968958Oct 1, 1996Paper

Isolation of a venom factor devoid of proteolytic activity from Taiwan habu (Trimeresurus mucrosquamatus): N-terminal sequence homology and no functional similarity to factors IX/X-binding proteins and botrocetin

Journal of Protein Chemistry
S H ChiouS H Wu

Abstract

One novel venom factor was isolated and purified from the venom of Taiwan habu (Trimeresurus mucrosquamatus) using two consecutive anion-exchange and gel-filtration chromatographies followed by cation-exchange HPLC. Further characterization of the purified protein indicated that it lacks the proteolytic activity toward fibrinogen molecules, suggesting that this protein factor does not belong to the familes of metalloproteinases and thrombin-like serine proteases commonly found in the crude venoms of various crotalid snakes. The purified protein exists as a native dimeric protein of 26 kDa, consisting of two closely similar subunits of 16 and 13 kDa, held together by disulfide linkage. N-Terminal sequence analysis revealed that both chains are homologous to each other at the N-terminal fragment and also similar to the factors IX/X-binding protein isolated from Trimeresurus flavoviridis and botrocetin from Bothrops jararaca. This study points to the existence of one new two-chain venom factor without fibrinogenase activity from Taiwan habu, which, in contrast to botrocetin, promotes platelet agglutination even in the absence of von Willebrand factor. Unlike factors IX/X-binding proteins, it did not show affinity to coagulation fa...Continue Reading

References

Feb 20, 1976·Biochimica Et Biophysica Acta·C Ouyang, C M Teng
Jan 1, 1986·Seminars in Thrombosis and Hemostasis·L Poller
Sep 1, 1970·Clinical Toxicology·J M Jiménez-Porras
Jan 1, 1968·Annual Review of Pharmacology·J M Jiménez-Porras
Jun 1, 1966·Toxicon : Official Journal of the International Society on Toxinology·J Meaume
Mar 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·K M BrinkhousR H Wagner
Jan 1, 1994·Pharmacology & Therapeutics·J B Bjarnason, J W Fox
Feb 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y UsamiK Titani
Jan 1, 1991·Platelets·C M Teng, T F Huang

❮ Previous
Next ❯

Citations

Jun 22, 2002·Toxicon : Official Journal of the International Society on Toxinology·Bon-Hun KooKwang-Hoe Chung
Mar 31, 2010·Toxicon : Official Journal of the International Society on Toxinology·Kenneth J Clemetson
Nov 26, 2009·Toxicon : Official Journal of the International Society on Toxinology·Yen-Shan ChenShyh-Horng Chiou
Jan 1, 2011·Journal of Aquatic Animal Health·Jorge Cáceres-MartínezGloria Padilla-Lardizábal

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.